绝经后2型糖尿病患者骨质疏松影响因素及骨转换特点

被引:12
作者
王燕
刘岩
张伟
李宝新
李玉坤
机构
[1] 河北医科大学第三医院内分泌科
关键词
绝经后; 2型糖尿病; 骨密度; 骨转换标记物;
D O I
暂无
中图分类号
R580 []; R587.1 [糖尿病];
学科分类号
100201 [内科学];
摘要
目的探讨绝经后2型糖尿病(T2DM)人群骨质疏松影响因素及骨转换特点及其防治策略。方法 150例绝经后T2DM住院患者测定骨密度(BMD)后分为骨量正常(NP)、骨量减低(DP)和骨质疏松(OP)组。登记年龄(Age),绝经年限(LOP),糖尿病病程(YSM),计算体重指数(BM I),测定空腹血糖(FPG)、餐后2 h血糖(PPG),空腹胰岛素(FIns)、餐后2 h胰岛素(2 h Ins),血Ⅰ型胶原C端肽(CTX-Ⅰ)、抗酒石酸酸性磷酸酶5b(TRACP5b)、骨特异性碱性磷酸酶(BALP)、雌激素(E2)。结果①绝经后T2DM人群OP发病率54%;②绝经后T2DM并发OP患者与骨量减少和骨量正常组比较绝经年限、糖尿病病程及血糖水平明显增高,胰岛素和E2水平明显降低(P<0.05);③OP组患者与骨量减少和骨量正常组比较CTX-Ⅰ、TRACP5b、BALP等骨转换指标明显升高(P<0.05);④CTX-Ⅰ与腰椎2~4、股骨颈BMD呈明显负相关(P<0.05),与大转子、粗隆间BMD无明显相关性;TRACP5b、BALP与腰椎2~4、股骨颈、大转子、粗隆间BMD呈明显负相关(P<0.05)。结论 LOP、血糖、YSM、FIns和E2水平可影响绝经后T2DM患者骨量;该人群骨重建特点为高转换型,骨吸收标记物TRACP5b可作为早期预测绝经后T2DM骨量减少及OP的敏感指标。
引用
收藏
页码:1506 / 1508
页数:3
相关论文
共 9 条
[1]
Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes [J].
Anaforoglu, Inan ;
Nar-Demirer, Ash ;
Bascil-Tutuncu, Neslihan ;
Ertorer, Melek Eda .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (01) :12-17
[2]
Increased bone resorption may play a crucial role in the occurrence of osteopenia in patients with type 2 diabetes: Possible involvement of accelerated polyol pathway in its pathogenesis [J].
Takizawa, Makoto ;
Suzuki, Kiyoshi ;
Matsubayashi, Tadashi ;
Kikuyama, Munetsugu ;
Suzuki, Haruhiko ;
Takahashi, Kazuto ;
Katsuta, Hidenori ;
Mitsuhashi, Junko ;
Nishida, Susumu ;
Yamaguchi, Shinya ;
Yoshimoto, Katsuhiko ;
Itagaki, Eiji ;
Ishida, Hitoshi .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (01) :119-126
[3]
Increased bone mineral density in postmenopausal women with type 2 diabetes mellitus [J].
Hadzibegovic, Irzal ;
Miskic, Blazenka ;
Cosic, Vesna ;
Prvulovic, Deiti ;
Bistrovic, Dragica .
ANNALS OF SAUDI MEDICINE, 2008, 28 (02) :102-104
[4]
Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus [J].
Kanazawa, I. ;
Yamaguchi, T. ;
Yamamoto, M. ;
Yamauchi, M. ;
Yano, S. ;
Sugimoto, T. .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 (12) :1675-1681
[5]
Combined treatment with a β-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice [J].
Pierroz, Dominique D. ;
Bouxsein, Mary L. ;
Rizzoli, Rene ;
Ferrari, Serge L. .
BONE, 2006, 39 (02) :260-267
[6]
Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients [J].
Yamagishi, S ;
Nakamura, K ;
Inoue, H .
MEDICAL HYPOTHESES, 2005, 65 (06) :1013-1015
[7]
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. [J].
de Liefde, II ;
van der Klift, M ;
de Laet, CEDH ;
van Daele, PLA ;
Hofman, A ;
Pols, HAP .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (12) :1713-1720
[8]
骨转换指标和骨密度监测治疗骨质疏松及其与骨折的关系 [J].
伍西羽 ;
伍贤平 ;
廖二元 .
中国骨质疏松杂志, 2007, (11) :797-802
[9]
血清骨特异性酸性磷酸酶的临床意义 [J].
薛延 ;
张海文 ;
杨立红 ;
王芊 ;
郭三巧 .
中华内分泌代谢杂志, 2003, (06)